CH628639A5 - Process for the preparation of furanose derivatives - Google Patents

Process for the preparation of furanose derivatives Download PDF

Info

Publication number
CH628639A5
CH628639A5 CH53176A CH53176A CH628639A5 CH 628639 A5 CH628639 A5 CH 628639A5 CH 53176 A CH53176 A CH 53176A CH 53176 A CH53176 A CH 53176A CH 628639 A5 CH628639 A5 CH 628639A5
Authority
CH
Switzerland
Prior art keywords
deoxy
lactone
carboxymethyl
compounds
formula
Prior art date
Application number
CH53176A
Other languages
German (de)
English (en)
Inventor
Gerhardus Johannes Dr Lourens
Johannes Mattheus Dr Koekemoer
Elise Margaretha Martha Venter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA00750317A external-priority patent/ZA75317B/xx
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH628639A5 publication Critical patent/CH628639A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH53176A 1975-01-16 1976-01-16 Process for the preparation of furanose derivatives CH628639A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA00750317A ZA75317B (en) 1975-01-16 1975-01-16 Novel chemical compounds and their use as intermediates
ZA751985 1975-04-01

Publications (1)

Publication Number Publication Date
CH628639A5 true CH628639A5 (en) 1982-03-15

Family

ID=27131118

Family Applications (1)

Application Number Title Priority Date Filing Date
CH53176A CH628639A5 (en) 1975-01-16 1976-01-16 Process for the preparation of furanose derivatives

Country Status (9)

Country Link
JP (1) JPS5195060A (xx)
CH (1) CH628639A5 (xx)
DE (1) DE2601333A1 (xx)
DK (1) DK17876A (xx)
FR (2) FR2318172A1 (xx)
GB (1) GB1532551A (xx)
IE (1) IE42941B1 (xx)
LU (1) LU74144A1 (xx)
NL (1) NL7600367A (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048194A (en) * 1976-04-14 1977-09-13 The Upjohn Company 6α-Methoxy-4α-hydroxy-2β-hydroxymethyl-3.alpha.-tetrahydropyranacetic acid 4α γ-lactone ethers and acylates
US4549030A (en) * 1982-12-13 1985-10-22 The Upjohn Company Organic compounds and process
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
EP0869794B1 (en) * 1995-12-22 2004-08-11 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436332A1 (de) * 1974-07-27 1976-02-12 Knoll Ag Substituierte tetrahydrofurane und verfahren zu deren herstellung

Also Published As

Publication number Publication date
IE42941L (en) 1976-07-16
IE42941B1 (en) 1980-11-19
JPS5195060A (xx) 1976-08-20
NL7600367A (nl) 1976-07-20
DE2601333A1 (de) 1976-07-22
GB1532551A (en) 1978-11-15
FR2318172B1 (xx) 1979-03-23
DK17876A (da) 1976-07-17
FR2318164A1 (fr) 1977-02-11
LU74144A1 (xx) 1977-07-22
FR2318164B1 (xx) 1979-02-16
FR2318172A1 (fr) 1977-02-11

Similar Documents

Publication Publication Date Title
CH632481A5 (de) Verfahren zur herstellung eines optisch aktiven norpinens.
DE69909455T2 (de) Polyethoxylierte ascorbinsäurederivate als neue antioxidantien und verfahren zu ihrer herstellung
DE69215070T2 (de) Verfahren zur herstellung von 3-dpa-lacton
DE2416193C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
DE2858694C2 (xx)
CH628639A5 (en) Process for the preparation of furanose derivatives
CH509297A (de) Verfahren zur Herstellung von in 17-Stellung durch ungesättigte Kohlenwasserstoffreste substituierten 11,13B-Dialkylgon-4-en-3,17B-diolen
EP0043967B1 (de) 2,9-Dioxatricyclo(4,3,1,0(3,7))decane
DE2463208C2 (de) Verfahren zur Herstellung von optisch aktiven bicyclischen Lactondiolen und deren racemischen Gemischen
DE2611788C2 (de) Fluorprostaglandine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
CH617186A5 (xx)
EP0000207A1 (de) Neue Prostaglandinderivate, deren Herstellung und pharmazeutische Präparate und Zwischenprodukte
EP0162235B1 (de) Enantiomerenreine acetalisch mono-geschützte Diole, deren Herstellung und Verwendung
CH628634A5 (de) Verfahren zur herstellung von 2,2'-bis(3,4-epoxy-5-oxotetrahydropyran)aether und produkt.
AT239454B (de) Verfahren zur Herstellung von 20-Cycloketalderivaten des 3β,5,17α-Trihydroxy-6β-methyl-16-methylen-5α-pregnan-20-ons
DE3536956A1 (de) Pyranderivate und ein verfahren zu ihrer herstellung
AT372080B (de) Verfahren zum herstellen von neuen optisch aktiven prost-5-en-13-in-carbonsaeurederivaten
DE69108587T2 (de) Verfahren und Zwischenprodukte zur Herstellung von optisch aktiven Chromanderivaten.
CH617424A5 (xx)
AT368524B (de) Verfahren zur herstellung von neuen in 16-stellung disubstituierten 3-ketosteroiden
AT238888B (de) Verfahren zur Herstellung von neuen, in 16-Stellung durch eine Methylgruppe substituierten 3α-Hydroxy-11,20-dioxo-21-pregnanglyoxylsäuren
DE2460977A1 (de) Sterisch einheitliche 11-oxaprostaglandine und verfahren zu deren herstellung
AT338755B (de) Verfahren zur herstellung von optisch aktiven cis-2-(2-hydroxyathyl)-3-cyclopenten-1-ol
AT361642B (de) Verfahren zur herstellung von neuen cholesterinderivaten
DE2560493C2 (de) 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane

Legal Events

Date Code Title Description
PL Patent ceased